CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionAustralianSuper Pty Ltd
Latest Disclosed Ownership104,673 shares
Latest Disclosed Value $ 30,915,171
AustralianSuper Pty Ltd reports 10.75% decrease in ownership of MX4A / CME Group Inc.

On May 7, 2026 - AustralianSuper Pty Ltd filed a 13F-HR form disclosing ownership of 104,673 shares of CME Group Inc. (DE:MX4A) valued at $26,738,718 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 117,286 shares of CME Group Inc.. This represents a change in shares of -10.75% during the quarter. The current value of the position is $22,797,779 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F CME GROUP COM 12572Q105 104,673 -12,613 -10.75 30,915 -3.48 0.1611
2026-02-05 2025-12-31 13F CME GROUP COM 12572Q105 117,286 -22,111 -15.86 32,028 -14.96 0.1489
2025-11-12 2025-09-30 13F/A-1 CME GROUP COM 12572Q105 139,397 -198,835 -58.79 37,664 -59.60 0.1779
2025-11-03 2025-09-30 13F CME GROUP COM 12572Q105 139,397 -198,835 37,664 0.1728
2025-08-01 2025-06-30 13F CME GROUP COM 12572Q105 338,232 -83,477 -19.79 93,224 -16.67 0.4720
2025-05-05 2025-03-31 13F CME GROUP COM 12572Q105 421,709 -455,971 -51.95 111,875 -45.11 0.6323
2025-01-30 2024-12-31 13F CME GROUP COM 12572Q105 877,680 -39,750 -4.33 203,824 0.69 0.9617
2024-10-28 2024-09-30 13F CME GROUP COM 12572Q105 917,430 -305,172 -24.96 202,431 -15.78 1.0090
2024-07-26 2024-06-30 13F CME GROUP COM 12572Q105 1,222,602 -49,057 -3.86 240,364 -10.85 1.3851
2024-04-26 2024-03-31 13F CME GROUP COM 12572Q105 1,271,659 281,249 28.40 269,617 29.26 1.5777
2024-01-16 2023-12-31 13F CME GROUP COM 12572Q105 990,410 -218,798 -18.09 208,580 -13.85 1.2524
2023-10-27 2023-09-30 13F CME GROUP COM 12572Q105 1,209,208 908 0.08 242,108 8.14 1.5683
2023-07-28 2023-06-30 13F CME GROUP COM 12572Q105 1,208,300 -41,552 -3.32 223,886 -6.47 1.4195
2023-04-21 2023-03-31 13F CME GROUP COM 12572Q105 1,249,852 207,607 19.92 239,372 35.94 1.4573
2023-02-01 2022-12-31 13F CME GROUP COM 12572Q105 1,042,245 -229,061 -18.02 176,087 -21.80 1.1712
2022-11-14 2022-09-30 13F CME GROUP COM 12572Q105 1,271,306 10,559 0.84 225,186 -12.74 1.6023
2022-07-13 2022-06-30 13F CME GROUP COM 12572Q105 1,260,747 238,555 23.34 258,075 6.14 1.5917
2022-04-29 2022-03-31 13F CME GROUP COM 12572Q105 1,022,192 0 0.00 243,139 4.66 1.3207
2022-01-24 2021-12-31 13F CME GROUP COM 12572Q105 1,022,192 2,577 0.25 232,314 17.82 1.2062
2021-11-12 2021-09-30 13F CME GROUP COM 12572Q105 1,019,615 0 0.00 197,173 -9.07 1.2650
2021-08-12 2021-06-30 13F CME GROUP COM 12572Q105 1,019,615 0 0.00 216,852 4.14 1.5131
2021-05-14 2021-03-31 13F CME GROUP COM 12572Q105 1,019,615 -352,598 -25.70 208,236 -16.64 1.6293
2021-02-11 2020-12-31 13F CME GROUP COM 12572Q105 1,372,213 119,390 9.53 249,811 19.18 1.8731
2020-11-16 2020-09-30 13F CME GROUP COM 12572Q105 1,252,823 188,503 17.71 209,610 21.17 1.7896
2020-08-13 2020-06-30 13F CME GROUP COM 12572Q105 1,064,320 17,308 1.65 172,995 -4.44 1.6776
2020-05-13 2020-03-31 13F CME GROUP COM 12572Q105 1,047,012 -123,778 -10.57 181,039 -22.96 2.3193
2020-02-10 2019-12-31 13F CME GROUP COM 12572Q105 1,170,790 -243,788 -17.23 235,001 -21.39 1.9822
2019-11-08 2019-09-30 13F CME GROUP COM 12572Q105 1,414,578 0 0.00 298,957 8.88 2.8279
2019-08-13 2019-06-30 13F CME GROUP COM 12572Q105 1,414,578 142,552 11.21 274,584 31.16 2.6396
2019-05-14 2019-03-31 13F CME GROUP COM CL A 12572Q105 1,272,026 149,399 13.31 209,350 -0.87 2.1864
2019-02-06 2018-12-31 13F CME GROUP COM CL A 12572Q105 1,122,627 110,300 10.90 211,189 22.56 3.2849
2018-11-08 2018-09-30 13F CME GROUP COM CL A 12572Q105 1,012,327 1,012,327 172,308 3.2600
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.